| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.627 | 16.545 | 16.754 | 23.033 | 29.403 | 19.921 | 21.961 | 25.032 | 26.905 | 21.470 |
| Total Income - EUR | 11.627 | 16.545 | 16.754 | 23.033 | 29.403 | 19.921 | 21.961 | 25.032 | 26.907 | 21.472 |
| Total Expenses - EUR | 5.594 | 9.434 | 10.439 | 11.933 | 17.286 | 18.223 | 16.699 | 17.601 | 17.571 | 16.902 |
| Gross Profit/Loss - EUR | 6.033 | 7.111 | 6.315 | 11.101 | 12.117 | 1.698 | 5.262 | 7.431 | 9.336 | 4.570 |
| Net Profit/Loss - EUR | 5.685 | 6.780 | 6.074 | 10.871 | 11.823 | 1.514 | 5.046 | 7.185 | 9.071 | 4.355 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neodermis Medical Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 248 | 164 | 81 | 625 | 514 | 814 | 746 | 118 | 58 | 58 |
| Current Assets | 23.651 | 12.675 | 11.723 | 21.948 | 28.956 | 26.941 | 26.028 | 28.332 | 30.510 | 25.001 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 379 | 376 | 369 | 397 | 355 | 370 | 362 | 463 | 372 | 370 |
| Cash | 23.272 | 12.299 | 11.354 | 21.551 | 28.600 | 26.570 | 25.666 | 27.870 | 30.138 | 24.631 |
| Shareholders Funds | 23.687 | 12.460 | 11.658 | 22.314 | 28.900 | 27.255 | 25.952 | 27.668 | 28.854 | 24.417 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 212 | 379 | 328 | 409 | 641 | 561 | 1.030 | 1.046 | 1.876 | 702 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neodermis Medical Center Srl